G
Gregg M. Stave
Researcher at Duke University
Publications - 32
Citations - 1321
Gregg M. Stave is an academic researcher from Duke University. The author has contributed to research in topics: Health care & Laboratory animal allergy. The author has an hindex of 15, co-authored 30 publications receiving 1258 citations. Previous affiliations of Gregg M. Stave include VCU Medical Center & Research Triangle Park.
Papers
More filters
Journal ArticleDOI
Effect of age and gender on the activity of human hepatic CYP3A
TL;DR: CYP3A activity was unaffected by age over the range of 27-83 years, suggesting that the aging-related alteration in the clearance of CYP3A substrates is secondary to changes in liver blood flow, size, or drug binding and distribution with aging.
Journal ArticleDOI
Effect of smoking status on productivity loss.
TL;DR: Current smokers incurred the highest productivity losses, which translated into higher costs to employers for current smokers, and costs were lower for former smokers and nonsmokers.
Journal ArticleDOI
Heterogeneity of CYP3A isoforms metabolizing erythromycin and cortisol.
Christine M. Hunt,Christine M. Hunt,Christine M. Hunt,Paul B. Watkins,Paul B. Watkins,Paul B. Watkins,Paul Saenger,Paul Saenger,Paul Saenger,Gregg M. Stave,Gregg M. Stave,Gregg M. Stave,Neal Barlascini,Neal Barlascini,Neal Barlascini,Charles O. Watlington,Charles O. Watlington,Charles O. Watlington,Jackson T. Wright,Jackson T. Wright,Jackson T. Wright,Philip S Guzelian,Philip S Guzelian,Philip S Guzelian +23 more
TL;DR: New noninvasive tests of CYP3A strongly suggest Cortisol 6β‐hydroxylation and erythromycin N‐demethylation are performed by distinct CYP 3A isoforms.
Journal ArticleDOI
Hepatic cytochrome P-4503A (CYP3A) activity in the elderly.
TL;DR: Performance of a new non-invasive test of the human hepatic glucocorticoid-inducible CYP3A in a geriatric cohort suggests that the gender-related heterogeneity in function of the glucoc Corticoid inducible human CYP2A persists during normal aging, and that the activity of CYP 3A may decrease in obesity.
Journal ArticleDOI
Laboratory animal allergy: an update.
Robert K. Bush,Gregg M. Stave +1 more
TL;DR: The prevention of LAA should be a major goal of an effective health and safety program in the animal research facility, and it can be accomplished by education and training of employees, reduction of exposure, use of personal protective gear, and changes in facility design.